Boston An independent LDT provider

Press releases

September 30, 2024 | REGULATORY

Change in number of shares and votes in Immunovia AB (publ)

Read press release
September 16, 2024

Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference

Read press release
September 12, 2024 | REGULATORY

Immunovia carries out a directed issue of units to guarantors in connection with the completed rights issue

Read press release
September 3, 2024 | REGULATORY

Immunovia announces final outcome in rights issue

Read press release
September 2, 2024 | REGULATORY

Immunovia publishes preliminary outcome in rights issue

Read press release
August 12, 2024 | REGULATORY

Immunovia publishes prospectus in connection with forthcoming rights issue

Read press release
August 6, 2024 | REGULATORY

Immunovia announces final terms of rights issue

Read press release
August 5, 2024 | REGULATORY

Immunovia Publishes Interim Report for January-June 2024

Read press release
August 5, 2024

Immunovia’s next generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health

Read press release
August 2, 2024

Immunovia files US patent application to protect its next-generation test

Read press release
August 1, 2024

Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy

Read press release
July 29, 2024

Invitation to Immunovia’s Q2 presentation

Read press release
1 2 3 4 5 31